Exascale Labs Holdings Inc. XLAB

 — 
2.43 (0.15) (5.81%) as of 25 Sep
Market cap
$74.0M
P/E
—

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership —

Capital & Financial Ratios

Market Cap 73.98
Revenue —
Net Income —
Free Cash Flow —
Net Debt —
Current Ratio —
Debt/Equity —
P/E ratio —
P/S ratio —
P/B ratio —
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2023 2024 2025 2026
Cash — — — —
Receivables — — — —
Inventory — — — —
Other — — — —
— — — —
2023 2024 2025 2026
Payables — — — —
ST’ Debt — — — —
Other — — — —
— — — —
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — —
Cash Flow — — —
Earnings — — —
Book Value — — —

Revenue

Year
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Year
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Year
in millions of $ · fiscal quarters ending in the months shown

EPS

Year
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
— — — — — — — — 9.88 2.35

Analyst estimates 2027–2029

Powerpack
Low Price
— — — — — — — — 10.09 11.17
High Price
— — — — — — — — — —
Employees
— — — — — — — — — —
Revenue/Emp
— — — — — — — — — —
Revenue
— — — — — — — — — —
Gross Margin
— — — — — — — — — —
EBT
— — — — — — — — — —
EBT Margin
— — — — — — — — — —
Net Income
— — — — — — — — — —
Depreciation
— — — — — — — — — —
Revenue/Sh
— — — — — — — — — —
Earnings/Sh
— — — — — — — — — —
Cash Flow/Sh
— — — — — — — — — —
Capex/Sh
— — — — — — — — — —
Free CF/Sh
— — — — — — — — — —
Book Value/Sh
— — — — — — — — — —
Shares
— — — — — — — — — —
PE Ratio
— — — — — — — — — —
PS Ratio
— — — — — — — — — —
PB Ratio
— — — — — — — — — —
EV/Sales
— — — — — — — — — —
EV/FCF
— — — — — — — — — —
Op' Cash Flow
— — — — — — — — — —
Capex
— — — — — — — — — —
FCF
— — — — — — — — — —
Working Cap'
— — — — — — — — — —
Total Debt
— — — — — — — — — —
Net Debt
— — — — — — — — — —
Sh' Equity
— — — — — — — — — —
ROA
— — — — — — — — — —
ROIC
— — — — — — — — — —
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Exascale Labs Holdings Inc. (XLAB) Latest News

News by impact score

Fine-tune

14 Sep

4

Exascale Labs Holdings Inc. and Compal signed a letter of intent to build a data-center-grade native 800 VDC validation platform. Letter of intent with Compal targets development of advanced 800 VDC data center technology with major strategic potential for XLAB.

31 Aug

4

Exascale Labs (XLAB) signed MOU with EnergyBank to develop AI compute powered by full-scale floating offshore wind turbine. MOU advances sustainable AI infrastructure with potential to shift company trajectory and market positioning.

27 Aug

4

Exascale Labs Holdings Inc. closed its business combination with D. Boral ARC Acquisition I Corp. Shares commenced trading on Nasdaq under ticker XLAB. Nasdaq listing after business combination delivers major capital market access and visibility boost.

stockrow.com/XLAB · For information only; not investment advice. · © 2026 stockrow.com